Delta-8 THC, a cannabinoid from cannabis, is sold in concentrated forms but lacks FDA approval, raising concerns about safety, mislabeling, and potential health risks. The FDA warns of the significant adverse effects reported, especially in children, and the use of unsafe chemicals in product manufacturing. Credit: FDA
1. Delta-8 THC products have not been evaluated or approved by the FDA for safe use and may be marketed in ways that put the public health at risk. Adverse events included, but were not limited to: hallucinations, vomiting, tremor, anxiety, dizziness, confusion, and loss of consciousness. 40% involved unintentional exposure to delta-8 THC and 82% of these unintentional exposures affected pediatric patients.
The natural amount of delta-8 THC in hemp is very low, and additional chemicals are needed to convert other cannabinoids in hemp, like CBD, into delta-8 THC . Concerns with this process include: To report adverse events in animals to the FDA’s Center for Veterinary Medicine, please download and submit Form FDA 1932a found at:The American Association of Poison Control Centers maintains the National Poison Data System , which houses de-identified case records of self-reported information collected from callers during exposure management and poison information calls managed by the country’s poison control centers .
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »